NES and Alzheimer disease: As expected, immunofluorescent analysis of the neural stem cell marker Nestin revealed a significant increase in the number and viability of Nestin+-labeled cells (NSCs) in the hippocampus of hDPSCs-treated AD mice, compared with that in the AD+PBS mice (Figure 4A, B).